INSIGHTS ON LIQUID DOSE MANUFACTURING
-
![Solving The Silicone Challenge]( "Solving The Silicone Challenge In Pre-Fillable Syringes")
Solving The Silicone Challenge In Pre-Fillable SyringesDiscover a technology platform that is revolutionizing the pre-fillable syringe market by solving the challenge of silicone sensitivity, ensuring stability for sensitive drugs.
-
![doctor holding vial of medicine-GettyImages-1287223643]( "Effective Strategies To Minimize Product Loss During Fill Finish")
Effective Strategies To Minimize Product Loss During Fill FinishEvery drop of high-value biologic lost in fill finish is money left on the table. Learn practical strategies to protect your yield.
-
![APSS 2000]( "A State-Of-The-Art Syringe Liquid Sampler")
A State-Of-The-Art Syringe Liquid SamplerDiscover a cutting-edge syringe liquid sampler for Life Sciences that offers USP <788> compliance, versatile syringe compatibility, and advanced features for precise particulate testing.
-
![GettyImages-1316775813 fill finish pharmaceutical bottles]( "Fill-Finish Contract Manufacturing: Trends, Challenges, And The Future")
Fill-Finish Contract Manufacturing: Trends, Challenges, And The FutureSee why it's important to partner with a CDMO that’s investing in advanced sterile fill-finish capabilities to meet the demands of complex biologics, gene therapies, and mRNA-based products.
-
Factors To Consider While Selecting Stoppers For Lyophilized Vials10/16/2024
Ensure the success and stability of your lyophilized products by choosing the right container-closure system — explore your stopper options, here.
-
Robust, High-Throughput Automated Solution For Water Endotoxin Testing4/21/2026
High-throughput water endotoxin testing doesn’t have to sacrifice consistency. Gain insight into how an automated workflow delivers reliable results, low variability, and strong control recovery.
-
CDMO Partnerships: Why Speed And Flexibility Matter Now More Than Ever12/29/2025
As demand for GLP-1s and biologics accelerates and timelines compress, it's become more crucial that pharmaceutical companies stay competitive and bring therapies to market faster by partnering with a CDMO.
-
Service Solutions Designed To Help You Gain Speed To Clinic And Market4/28/2025
Discover how speed, cost, and regulatory acceptance impact drug manufacturing, as well as learn about aseptic filling challenges and how innovative services can enhance your efficiency and compliance.
-
BioTitan Retention Device Overview5/29/2025
Learn about a retention device that provides robust fortification for single-use assemblies. Its 360-degree seal strengthens connections, reduces leak risks, and ensures process integrity for fluid transfer.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
![Microcell Vial Filler Feature]( "Closed Robotic Isolator For Pharmaceutical Vial Filling")
The Microcell™ Vial Filler is a closed robotic isolator for pharmaceutical vial filling that enables small batch flexibility and standardized manufacturing.
-
![Field Service Automation]( "Maximize Efficiency With Gibco Process Liquids And Buffers")
View a list of Gibco™ process liquids catalog products, process liquids and buffers library, and custom solutions.
-
![ast - Peristaltic Pump]( "Peristaltic Pump System For Aseptic Filling Of Pharmaceuticals")
This gentle peristaltic pump is designed for dispensing shear-sensitive products. It uses pre-sterilized single-use fluid paths that can easily be installed in the pump in an isolated setting through the glove port, ensuring sterility.
-
![Dec Group 2]( "Production-Scale Pharmaceutical Filling Systems")
Dec‘s philosophy is to develop customer-specific modules and equipment. Starting with agreed project scope, intensive brainstorm sessions, strong design processes and (customer) reviews, the aim is to deliver an innovative filling solution. During the concept development, risk analysis is an important tool in the decision-making process.
-
![cell and gene]( "Cell And Gene Therapy Development Aseptic R&D Filling Equipment")
Cell and gene therapies have increased in popularity in recent years, and thanks to their ability to provide one-time treatments these therapies will play a significant role in treating some of the world's most challenging diseases. These drug products treat patients afflicted with genetic disorders and cancers by targeting the source of disease and altering its genetic makeup to eliminate its cause or symptoms. These therapies are expensive and complex and have been proven effective in numerous cases, but they present a challenge in producing them at scale and at a reasonable cost.
